ReviewACS central science2025
SERS Cheminformatics: Opportunities for Data-Driven Discovery and Applications.
Review in ACS central science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Bioactive Gold Plasmonic Interfaces Meet Artificial Intelligence: Advancing Saliva-Based Surface-Enhanced Raman Spectroscopy Diagnostics.Small (Weinheim an der Bergstrasse, Germany) · 2026Review
- Raman reporters for SERS/SERRS biosensing and biomedicine: design, applications, and challenges.Mikrochimica acta · 2026Review
- Surface-Enhanced Raman Spectroscopy for Viral Diagnostics: Principles, Strategies, Clinical Challenges, and Future Directions.Chemical reviews · 2026Review
- AI/ML-Assisted SERS Biosensing for Biomolecular Detection: From Direct Spectral Response to Integrated Diagnostic Systems.Biosensors · 2026Review
- Reconfigurable Nanogap SERS for Multiscale Molecular Sensing on Curved Surfaces.Small (Weinheim an der Bergstrasse, Germany) · 2026Article
- Next-Generation SERS Probes: Engineering Hotspots, Intelligent Molecular Targeting, and AI-Driven Spectral Analysis for Emerging Applications.Nanomaterials (Basel, Switzerland) · 2026Review
- Machine Learning-Enabled Intelligent Analysis of Surface-Enhanced Raman Scattering: Methods, Applications, and Perspectives.Molecules (Basel, Switzerland) · 2026Review
- Quantitative Surface-Enhanced Raman Spectroscopy: Challenges, Strategies, and Prospects.Molecules (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Surface-enhanced Raman scattering (SERS) is a powerful analytical technique offering ultrasensitive, nondestructive molecular fingerprinting. However, challenges such as spectral overlap, noise, and signal variability, especially in complex mixtures, limit its reliability and reproducibility. With increasing volumes of complex SERS data, there is a pressing need for advanced tools to manage and interpret this information. Cheminformatics amalgamates chemical knowledge with computational methods to deliver solutions for spectral preprocessing, database management, molecular modeling, pattern recognition, and multimodal data integration. This Outlook presents a vision for uniting SERS and cheminformatics to enhance the reliability of (bio)-chemical analysis and discovery. We propose a conceptual framework built upon four interconnected pillars: (1) centralized SERS databases, (2) molecular modeling for mechanistic insights, (3) machine learning (ML) for spectral analysis, and (4) automation and artificial intelligence for expanding the SERS chemical space. Together, these four pillars form a dynamic, feedback-driven system that enhances interpretability, accelerates data-driven discovery, and facilitates real-time SERS analysis. The symbiotic relationship between SERS and cheminformatics positions this integration at the forefront of data-driven chemical research with transformative applications in materials science, catalysis, biomedical diagnostics, and environmental monitoring.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.